- Editorials Linvencovir: Paving the way for functional cure in hepatitis B
- Jiwon Yang, Jonggi Choi
- Clin Mol Hepatol. 2024;30(2):164-165.
- Correspondences Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply
- Hyeyeon Hong, Jonggi Choi
- Clin Mol Hepatol. 2024;30(2):272-273.
- Original Articles Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
- Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
- Clin Mol Hepatol. 2024;30(1):49-63.
- Reviews Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
- Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
- Clin Mol Hepatol. 2021;27(3):402-412.
- Editorials Lamivudine: fading into the mists of time
- Jonggi Choi, Young-Suk Lim
- Clin Mol Hepatol. 2017;23(4):314-315.